GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cdkn1b | affects expression | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | Valproic Acid affects the expression of CDKN1B mRNA | PMID:25979313 | Cdkn1b | decreases expression | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of CDKN1B mRNA | PMID:23179753 PMID:28001369 | Cdkn1b | increases expression | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased expression of CDKN1B protein | PMID:21737646 | Cdkn1b | increases expression | ISO | Cdkn1b (Mus musculus) | 6480464 | CTD | Valproic Acid results in increased expression of CDKN1B protein | PMID:21708246 | Cdkn1b | multiple interactions | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA; Celecoxib promotes the reaction [Valproic Acid results in increased expression of CDKN1B protein]; Valproic Acid promotes the reaction [Celecoxib results in increased expression of CDKN1B protein] | PMID:17653085 PMID:21737646 | |
Go Back to source page | Continue to Ontology report |